Log in to save to my catalogue

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5833787

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

About this item

Full title

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

Publisher

London: Nature Publishing Group UK

Journal title

Oncogenesis (New York, NY), 2018-01, Vol.7 (1), p.4-12, Article 4

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

We previously found that therapeutic targetable fusions are detected across various cancers. To identify therapeutic targetable fusion in uterine cervical cancer, for which no effective gene targeted therapy has yet been clinically applied, we analyzed RNA sequencing data from 306 cervical cancer samples. We detected 445 high confidence fusion tran...

Alternative Titles

Full title

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5833787

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5833787

Other Identifiers

ISSN

2157-9024

E-ISSN

2157-9024

DOI

10.1038/s41389-017-0018-2

How to access this item